1231930-82-7: Abemaciclib Mesylate

Status: Under Development

Abemaciclib Mesylate (CAS No: 1231930-82-7) belonging to the class of Aminopyridines is an inhibitor of cyclin-dependent kinases 4 and 6 that is used in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.

Contact us

Additional information on CAS 1231930-82-7

Catalogue No. VL4990001
CAS No. 1231930-82-7
Molecular Formula C₂₈H₃₆F₂N₈O₃S
Molecular Weight 602.7
Parent drug Abemaciclib
IUPAC Name N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine Methanesulfonate
Synonyms N/A
References Kim, Esther S. “Abemaciclib: First Global Approval.” Drugs, vol. 77, no. 18, Nov. 2017, pp. 2063–70, https://doi.org/10.1007/s40265-017-0840-z.
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1231930-82-7: Abemaciclib Mesylate

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.